STERIS plc (STE) Form 144 shows 5,008-share insider sale filing

Rhea-AI Filing Summary

STERIS plc (STE) insider filed a Form 144 to sell 5,008 ordinary shares. The planned sale is through Charles Schwab & Co., Inc. on the NYSE, with an approximate sale date of 11/21/2025. The shares listed have an aggregate market value of $1,312,096.00, and the table notes 98,147,009 shares outstanding. The seller acquired these shares on 11/21/2025 through an employee stock option exercise, using a broker payment for a cashless exercise.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	5008	1312096.00	98147009	11/21/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	11/21/2025	Employee Stock Option Exercise	STERIS plc			5008	11/21/2025	Broker Payment for Cashless Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does STERIS plc (STE) disclose in this Form 144 filing?

The filing reports that an insider of STERIS plc (STE) plans to sell 5,008 ordinary shares under Rule 144, providing details on the broker, timing, and how the shares were acquired.

How many STERIS plc (STE) shares are planned to be sold and through which broker?

The notice covers the planned sale of 5,008 ordinary shares of STERIS plc through Charles Schwab & Co., Inc. on the NYSE.

What is the aggregate market value of the STERIS (STE) shares in this Form 144?

The Form 144 lists an aggregate market value of $1,312,096.00 for the 5,008 ordinary shares to be sold.

How and when were the STERIS plc (STE) shares being sold acquired?

The 5,008 ordinary shares were acquired on 11/21/2025 via an employee stock option exercise, with a broker payment for a cashless exercise.

On which exchange will the STERIS plc (STE) shares be sold and when?

The filing states an approximate sale date of 11/21/2025 and names the NYSE as the securities exchange for the sale.

How many STERIS plc (STE) shares are shown as outstanding in the Form 144 table?

The securities information table shows 98,147,009 shares of STERIS plc ordinary shares outstanding.